About Us

Mission: Onset Dermatologics is dedicated to the revolutionary idea that we create prescription dermatologic products patients love to use. We will offer innovative topical therapies for the treatment of skin disorders that dermatology clinicians prescribe because our products improve patient adherence which in turn improves clinical outcomes and patient quality of life.

The Company

Onset Dermatologics, a PreCision Dermatology company, is an emerging leader in the development and commercialization of novel prescription products for the treatment of skin disorders. Our emphasis is on providing innovative therapies that address the unmet clinical needs of dermatologists and their patients. We offer optimized, innovative, practical and cost-effective dermatological products. Many of our products feature our proprietary Delevo® foam technology, a drug delivery platform that provides enhanced penetration of proven active ingredients to the skin with optimized tolerability and improvement of the natural skin barrier.

The key to Onset Dermatologics success is the integrated commercial and research & development team. This team is dedicated to understanding unmet therapeutic needs and implementing streamlined approaches to incorporate the latest advances in drug delivery and formulation technology to develop and commercialize therapies to meet those needs. As a PreCision Dermatology company, Onset Dermatologics is supported by the resources of a well-funded parent company led by Jeff Nugent, a visionary skin care executive leader. Mr. Nugent is the former President and CEO of Neutrogena during the high growth period following its acquisition by Johnson & Johnson and former President and CEO of Revlon. The focus of Onset Dermatologics and Precision is exclusively dedicated to care of the skin and the important people associated with it.